NOV 07, 2022 3:00 AM PST

Compound Produced by Pomegranates Could Help Fight Cancer

WRITTEN BY: Katie Kokolus

Since ancient times, scientific and anecdotal evidence has noted many health benefits associated with pomegranates propelling this fruit into the “superfood” category.  Last year, Labroots discussed some of the immune-favoring properties of pomegranates, including anti-oxidant, anti-microbial, and anti-inflammatory activities.  While no studies have established direct connections between pomegranates and the prevention or treatment of cancer, a recent report published in Immunity has provided some new evidence supporting this relationship.

The study focused on urolithin A (UA), a chemical compound produced from ellagitannins, a molecule found in pomegranates.  Microbes in the gut produce UA when processing foods rich in ellagitannins, such as pomegranates.  The researchers fed tumor-bearing mice a diet supplemented with UA or a standard (control) diet.  Consumption of UA conferred significantly slower growth of tumors in the intestine of the mice.  Along with the improved tumor control, the researchers identified an increase of CD8+ T cells in the tumors of UA-fed mice. 

CD8+ T cells, also called cytotoxic T cells, play an essential role in the anti-tumor immune response.  These immune cells identify and kill invading cells, including cancer cells.  To test the importance of these cells in UA-driven tumor control, the researchers utilized a specialized strain of mice (called Rag1 KO) which produce no mature T cells.  Intestinal tumors grew normally in these mice when fed the UA diet indicating that the absence of mature T cells eliminated the impact of UA on tumor growth. 

The researchers then sought to confirm that CD8+ T cells, and no other immune cell subsets absent in the Rag1 KO mice, facilitated the tumor control in UA-fed mice.  Thus, they depleted CD8+ T cells from standard mice, leaving all other immune cell subsets intact.  Like observations in the Rag1 KO mice, normal mice depleted of CD8+ T cells received no benefit from the UA diet.  

Next, the researchers explored the role of T memory stem cells (TSCM), a type of CD8+ T cell with long-term memory and survival functions associated with effective anti-tumor immunity.  The study showed that UA increased numbers of TSCM.  The researchers demonstrated that UA-driven TSCM expansion relied on mitophagy, a biological process to degrade damaged mitochondria. 

The authors conclude that UA’s ability to induce mitophagy promotes CD8+ T cell-driven anti-tumor immunity.  While clinical trials to evaluate the impact on human cancer, the evidence presented in this study suggests the mechanism by which UA, a component derived from pomegranates, could translate from the bench to the bedside. 

 

Sources: Immunity, Eur J Clin Nutr, Tannins, Nat Med, Cells

About the Author
Doctorate (PhD)
PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
OCT 10, 2022
Cancer
Experimental Drug Can Create Targets for Cancer-Killing Drugs
Experimental Drug Can Create Targets for Cancer-Killing Drugs
Immunotherapies continue to expand the cancer treatment landscape, providing new and exciting approaches to treat tumors ...
NOV 09, 2022
Genetics & Genomics
Want to Study Copy Number Alterations in Cells? Bring MACHETE
Want to Study Copy Number Alterations in Cells? Bring MACHETE
Sure, MACHETE is a cool name, but the researchers that developed the technique are hoping people don't focus solely on t ...
NOV 15, 2022
Genetics & Genomics
Revealing the Mutations that Make Melanoma Immortal
Revealing the Mutations that Make Melanoma Immortal
Telomeres cap the ends of chromosomes, preventing breakage. Some cancer cells can use those protective caps to their adv ...
DEC 07, 2022
Drug Discovery & Development
Mucus Eating Microbe Contributes to Major Cancer Treatment Complication
Mucus Eating Microbe Contributes to Major Cancer Treatment Complication
  Akkermansia muciniphila loves to degrade mucin, a molecule found in mucus. We’ve identified this and other ...
DEC 20, 2022
Clinical & Molecular DX
Creatine Biomarker Could Be Used to Screen for Deadly Myocarditis After Cancer Treatment
Creatine Biomarker Could Be Used to Screen for Deadly Myocarditis After Cancer Treatment
Immune checkpoints are a part of the immune system that prevents the body’s immune response from destroying health ...
JAN 19, 2023
Cell & Molecular Biology
Revealing the Molecules Underlying Metastasis
Revealing the Molecules Underlying Metastasis
Cancer is at its deadliest when it metastasizes - when cancer cells break away from a tumor and migrate to other tissues ...
Loading Comments...